Reilly Financial Advisors’s Healthcare Realty Trust Incorporated HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$6K Hold
200
﹤0.01% 819
2021
Q3
$6K Hold
200
﹤0.01% 735
2021
Q2
$6K Hold
200
﹤0.01% 780
2021
Q1
$6K Hold
200
﹤0.01% 778
2020
Q4
$6K Hold
200
﹤0.01% 701
2020
Q3
$6K Hold
200
﹤0.01% 660
2020
Q2
$6K Hold
200
﹤0.01% 688
2020
Q1
$6K Hold
200
﹤0.01% 667
2019
Q4
$7K Hold
200
﹤0.01% 701
2019
Q3
$7K Hold
200
﹤0.01% 706
2019
Q2
$6K Hold
200
﹤0.01% 766
2019
Q1
$6K Hold
200
﹤0.01% 780
2018
Q4
$6K Hold
200
﹤0.01% 743
2018
Q3
$6K Hold
200
﹤0.01% 815
2018
Q2
$6K Hold
200
﹤0.01% 792
2018
Q1
$6K Hold
200
﹤0.01% 761
2017
Q4
$6K Hold
200
﹤0.01% 763
2017
Q3
$6K Hold
200
﹤0.01% 739
2017
Q2
$7K Buy
+200
New +$6.73K ﹤0.01% 734

Other funds holding HR

Reilly Financial Advisors's HR Position: Q4 2021 in Review

Reilly Financial Advisors held its Healthcare Realty Trust Incorporated (HR) position steady in Q4 2021 at 200 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Reilly Financial Advisors first reported a position in HR in Q2 2017 and has held it in 19 quarters since. The position peaked at $7K in Q4 2019. 300 funds tracked by Wall St. Rank hold HR as of Q4 2021.

  • Reilly Financial Advisors held 200 shares of Healthcare Realty Trust Incorporated worth $6K as of Q4 2021.
  • Reilly Financial Advisors left its Healthcare Realty Trust Incorporated share count unchanged in Q4 2021.
  • Healthcare Realty Trust Incorporated made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #819 holding.
  • Reilly Financial Advisors first reported a position in Healthcare Realty Trust Incorporated in Q2 2017 and has held it in 19 quarters since.
  • Reilly Financial Advisors's Healthcare Realty Trust Incorporated position peaked at $7K in Q4 2019.
  • 300 funds tracked by Wall St. Rank held Healthcare Realty Trust Incorporated as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.